“Adaptive pathways” to drug authorisation: adapting to industry?

Courtney Davis; Joel  Lexchin; Tom Jefferson; Peter Gøtzsche; Martin McKee

doi:10.1136/bmj.i4437

“Adaptive pathways” to drug authorisation: adapting to industry?

Courtney Davis
, Joel Lexchin
, Tom Jefferson
, Peter Gøtzsche
, Martin McKee

University of Toronto
University of Oxford
Nordic Cochrane Centre
LSHTM London School of Hygiene and Tropical Medicine

Research output: Contribution to journal › Comment/debate › peer-review

46 Citations (Scopus)

456 Downloads (Pure)

Abstract

Evidence for benefits to patients and public health of adaptive pathways is lacking or contradictory, say Courtney Davis and colleagues

Original language	English
Article number	i4437
Journal	British Medical Journal
Volume	354
Early online date	16 Aug 2016
DOIs	https://doi.org/10.1136/bmj.i4437 https://doi.org/10.1136/bmj.i4437
Publication status	E-pub ahead of print - 16 Aug 2016

Access to Document

10.1136/bmj.i4437
10.1136/bmj.i4437Licence: CC BY-NC

“Adaptive pathways” to drug authorisation_DAVIS Epub 16Aug2016 GOLD VOR CC BY NCFinal published version, 561 KBLicence: CC BY-NC

Cite this

@article{3c5b27059bc24b6893a6e2252ebc60e7,

title = "“Adaptive pathways” to drug authorisation: adapting to industry?",

abstract = "Evidence for benefits to patients and public health of adaptive pathways is lacking or contradictory, say Courtney Davis and colleagues",

author = "Courtney Davis and Joel Lexchin and Tom Jefferson and Peter G{\o}tzsche and Martin McKee",

year = "2016",

month = aug,

day = "16",

doi = "10.1136/bmj.i4437",

language = "English",

volume = "354",

journal = "British Medical Journal",

issn = "0959-535X",

publisher = "BMJ Publishing Group Ltd",

}

TY - JOUR

T1 - “Adaptive pathways” to drug authorisation

T2 - adapting to industry?

AU - Davis, Courtney

AU - Lexchin, Joel

AU - Jefferson, Tom

AU - Gøtzsche, Peter

AU - McKee, Martin

PY - 2016/8/16

Y1 - 2016/8/16

N2 - Evidence for benefits to patients and public health of adaptive pathways is lacking or contradictory, say Courtney Davis and colleagues

AB - Evidence for benefits to patients and public health of adaptive pathways is lacking or contradictory, say Courtney Davis and colleagues

U2 - 10.1136/bmj.i4437

DO - 10.1136/bmj.i4437

M3 - Comment/debate

SN - 0959-535X

VL - 354

JO - British Medical Journal

JF - British Medical Journal

M1 - i4437

ER -

“Adaptive pathways” to drug authorisation: adapting to industry?

Abstract

Access to Document

Fingerprint

Cite this